Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:443-450

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liao, H.-S.
Right arrow Articles by Izumo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, H.-S.
Right arrow Articles by Izumo, S.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetically altered mice
(Circulation Research. 2001;88:443.)
© 2001 American Heart Association, Inc.


Molecular Medicine

Cardiac-Specific Overexpression of Cyclin-Dependent Kinase 2 Increases Smaller Mononuclear Cardiomyocytes

Hai-Sun Liao, Peter M. Kang, Hirotaka Nagashima, Naohito Yamasaki, Anny Usheva, Bo Ding, Beverly H. Lorell, Seigo Izumo

From the Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.

Correspondence to Seigo Izumo, MD, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215. E-mail sizumo{at}caregroup.harvard.edu

Abstract—Cyclin-dependent kinase 2 (cdk2) plays a critical role in the G1- to S-phase checkpoint of the cell cycle. Adult cardiomyocytes are believed to withdraw from the cell cycle. To determine whether forced overexpression of cdk2 results in altered cell-cycle regulation in the adult heart, we generated transgenic mice specifically overexpressing cdk2 in hearts. Transgenic hearts expressed high levels of both cdk2 mRNA and catalytically active cdk2 proteins. Cdk2 overexpression significantly increased the levels of cdk4 and cyclins A, D3, and E. There was an increase in both DNA synthesis and proliferating cell nuclear antigen levels in the adult transgenic hearts. The ratio of heart weight to body weight in cdk2 transgenic mice was significantly increased in neonatal day 2 but not in adults compared with that of wild-type mice. Analysis of dispersed individual adult cardiomyocytes showed a 5.6-fold increase in the proportion of smaller mononuclear cardiomyocytes in the transgenic mice. Echocardiography revealed that transgenic heart was functionally normal. However, adult transgenic ventricles expressed ß-myosin heavy chain and atrial natriuretic factor. Surgically induced pressure overload caused an exaggerated maladaptive hypertrophic response in transgenic mice but did not change the proportion of mononuclear cardiomyocytes. The data suggest that overexpression of cdk2 promotes smaller, less-differentiated mononuclear cardiomyocytes in adult hearts that respond in an exaggerated manner to pressure overload.


Key Words: cardiomyocyte regeneration • cell cycle • cyclin-dependent kinase




This article has been cited by other articles:


Home page
HeartHome page
R J Hassink, H Nakajima, H O Nakajima, P A Doevendans, and L J Field
Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction
Heart, July 15, 2009; 95(14): 1159 - 1164.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Qiu, H. Dai, K. Jain, R. Shah, C. Hong, J. Pain, B. Tian, D. E. Vatner, S. F. Vatner, and C. Depre
Characterization of a Novel Cardiac Isoform of the Cell Cycle-related Kinase That Is Regulated during Heart Failure
J. Biol. Chem., August 8, 2008; 283(32): 22157 - 22165.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Hassink, K. B. Pasumarthi, H. Nakajima, M. Rubart, M. H. Soonpaa, A. B. de la Riviere, P. A. Doevendans, and L. J. Field
Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction
Cardiovasc Res, April 1, 2008; 78(1): 18 - 25.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. McKoy, K. A. Bicknell, K. Patel, and G. Brooks
Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation
Cardiovasc Res, May 1, 2007; 74(2): 304 - 312.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Ahuja, P. Sdek, and W. R. MacLellan
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Physiol Rev, April 1, 2007; 87(2): 521 - 544.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Anversa, A. Leri, and J. Kajstura
Cardiac Regeneration
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1769 - 1776.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. M. Ledda-Columbano, F. Molotzu, M. Pibiri, C. Cossu, A. Perra, and A. Columbano
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes
FASEB J, January 1, 2006; 20(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. R. MacLellan, A. Garcia, H. Oh, P. Frenkel, M. C. Jordan, K. P. Roos, and M. D. Schneider
Overlapping Roles of Pocket Proteins in the Myocardium Are Unmasked by Germ Line Deletion of p130 plus Heart-Specific Deletion of Rb
Mol. Cell. Biol., March 15, 2005; 25(6): 2486 - 2497.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. M. Regula, M. J. Rzeszutek, D. Baetz, C. Seneviratne, and L. A. Kirshenbaum
Therapeutic opportunities for cell cycle re-entry and cardiac regeneration
Cardiovasc Res, December 1, 2004; 64(3): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. W. Chaudhry, N. H. Dashoush, H. Tang, L. Zhang, X. Wang, E. X. Wu, and D. J. Wolgemuth
Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium
J. Biol. Chem., August 20, 2004; 279(34): 35858 - 35866.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. Colomer, M. Terasawa, and A. R. Means
Targeted Expression of Calmodulin Increases Ventricular Cardiomyocyte Proliferation and Deoxyribonucleic Acid Synthesis during Mouse Development
Endocrinology, March 1, 2004; 145(3): 1356 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. K Busk, J. Bartkova, C. C Strom, L. Wulf-Andersen, R. Hinrichsen, T. E.H Christoffersen, L. Latella, J. Bartek, S. Haunso, and S. P Sheikh
Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro
Cardiovasc Res, October 1, 2002; 56(1): 64 - 75.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. B.S. Pasumarthi and L. J. Field
Cardiomyocyte Cell Cycle Regulation
Circ. Res., May 31, 2002; 90(10): 1044 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. D. Grounds, J. D. White, N. Rosenthal, and M. A. Bogoyevitch
The Role of Stem Cells in Skeletal and Cardiac Muscle Repair
J. Histochem. Cytochem., May 1, 2002; 50(5): 589 - 610.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. D. Schneider and W. R. MacLellan
Cyclin-Dependent Kinase-2 in the Birth and Death of Cardiac Muscle Cells
Circ. Res., March 2, 2001; 88(4): 367 - 369.
[Full Text] [PDF]